Trade Mark Journal No.2026/041 9 October 2026

WO0000001939398 (5,9,42,44)

Office of origin: United States of America

Date of International Registration:13 March 2026
Date of designation in the UK: 13 March 2026
Image for mark 1939398 CELCUITY

International priority date claimed: 15 September 2025 (United States of America) (99392811)
International priority date claimed: 15 September 2025 (United States of America) (99392819)
Class 5
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in oncology clinical trials.
Class 9
Downloadable electronic publications in the nature of articles and posters in the field of oncology.
Class 42
Providing medical and scientific research information in the field of cancer treatment; providing information about clinical trials in the field of oncology via a website.
Class 44
Medical testing services for diagnostic and treatment purposes in the field of cancer; providing medical information to healthcare professionals and patients regarding cancer therapies; consulting services in the field of oncology treatment options.

Celcuity Inc.

Representative: Anthony Laurentano Nelson Mullins Riley & Scarborough LLP, One Financial Center, Suite 3500, Boston MA 02111, UNITED STATES OF AMERICA